2021 will prove to be pivotal for the pot market. Investors stand to rake in huge gains. And today we have a new play that will allow you to take advantage of the hype.
If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!
his month, COVID-19 continues to be the focal point for investors. And it’s dictating where we search for April’s bonus pick. After all, where should you invest in a crisis? The answer might be more straightforward than you’d expect. When times get tough, buy what’s working.
One of our positions just got a huge monetary boost from the DoD. And the market loves it, sending shares up almost 100% in a week. We await to see what happens next with the first round of clinical data.
This stock has doubled for us in less than a year, swelling to a $323 billion market cap. Let’s take a partial profit on this great tech company and watch it keep growing.
AI in 2020 was a huge topic with full backing from the White House. And the momentum means 2021 for AI looks stellar. Today we’re taking a closer look at a recent IPO that stands to win big from the increasing prevalence of artificial intelligence.
U.S. markets were down most of the day Thursday, before climbing to a modest gain by close. But something eye-opening happened after the market closed. As I write to you on Thursday evening, Dow futures are rallying by 750 points! And it is all because of good news from one of our portfolio recommendations…
This week, the FDA yet again showed who’s in charge. And last week’s sell timing turned out to be perfect. Today, we’re selling two plays that have lost traction to open up our portfolio for better opportunities down the line.